DEAL TERMS Priced $15.00 Range $15–$17 Shares 9,375,000 Raised $150M First trade Not filed Valuation at IPO Not filed Lead bank Not filed Aspen Neuroscience, Inc. BELLIPO DOSSIER · BD·ASPE·2026 · v1.0

Aspen Neuroscience, Inc. (ASPE) IPO

ASPE · Nasdaq · Priced · 3 min read BIOTECH · CLINICAL STAGE IN BRIEF
THE LIFECYCLE ENGINE™ Stage 3 of 5

Where Aspen Neuroscience stands today

Every IPO moves through five stages. Bellipo moves ASPE the moment its record changes.

RADAR No terms yet Oct 9, 2026 READY Terms set Oct 26, 2026 PINGNOW Priced Priced $15.00 · Oct 30, 2026 STRIKE First trade Expected Nov 3, 2026 ORBIT Trading On the record Not filed Next on the record Quiet period ends (est. Nov 24, 2026) · First quarterly report (10-Q) (est. Dec 14, 2026) · Lock-up ends (not dated)
CHAPTER 01

The company

COMPANY PROFILE
CHAPTER 02

The drugs

THE FULL DOSSIER IS FREE

Create a free account to read the rest.

The dates ahead, the money, the deal, the Bellipo Demand Index (BDI), the risks and our bottom line.

FREE BETA · NO CARD · OPENS DEC 1, 2026
PROVENANCE RECEIPT

BD·ASPE·2026 · v1.0 · every figure cited · View the full source record

Provenance Receipt

Every figure in this dossier traces to the filings below; figures Bellipo computed are labelled as Bellipo arithmetic.

Every figure comes from the S-1 and carries its printed page. Nothing is estimated. Below is each stored row and its source, so you can check it yourself. How we grade sources.

Terms of record · Issuer release Accepted Terms
FieldValueSource
Terms of recordIssuer releaseIssuer release via globenewswire.com · retrieved Oct 30, 2026 · open release
Marketed range$15.00–$17.00Range as disclosed in the registration statement. A marketed band is not terms of record.
Shares offered9,375,000Base offering as disclosed in the filing. Excludes any underwriter option unless stated in the body.
SEC identifier0002124080Central Index Key. View this company's filings on EDGAR.
Registration filingon fileOpen the registration statement
Pricing
FieldValueSource
Offer price$15.00Final price as filed. Priced Oct 30, 2026.
Pricing sourceEDGAR_424B4The channel that supplied the price. Recorded for audit; it does not override the provenance tier.
Score frozen30 Oct 2026 · 21:00 ETThe instant the demand read was locked. It is not restated after the First Print. Methodology.
Dossier revisedOct 29, 2026Sections are versioned. Corrections are filed publicly rather than edited away.
Strike · First trade

Not yet traded. This section fills in when the First Print is established.

Lockup

No lock-up length is on file for this offering.

BELLIPO · FREE BETA

Every US IPO, from the first filing onward.

Dossiers like this one, the Lifecycle Engine and the Bellipo Demand Index (BDI) for every IPO. Free account, no card.

FREE BETA · OPENS DEC 1, 2026
Read the full Aspen Neuroscience dossier free. The dates ahead, the money, the risks and our bottom line. Create free account The Dispatch · Dossiers